SKIN logo

Beauty Health (SKIN) EBITDA

Annual EBITDA

-$56.00 M
-$136.75 M-169.35%

December 31, 2023


Summary


Performance

SKIN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSKINprofitabilitymetrics:

Quarterly EBITDA

-$4.32 M
-$15.54 M-138.50%

September 30, 2024


Summary


Performance

SKIN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSKINprofitabilitymetrics:

TTM EBITDA

$21.77 M
+$54.59 M+166.33%

September 30, 2024


Summary


Performance

SKIN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSKINprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

SKIN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-169.3%+92.7%+150.7%
3 y3 years-1895.0%-128.7%-10.8%
5 y5 years-359.8%-7.1%+639.9%

SKIN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-169.3%+84.0%-110.1%+92.7%-73.3%+106.3%
5 y5-year-169.3%+84.0%-110.1%+97.9%-73.3%+106.3%
alltimeall time-169.3%+84.0%-110.1%+97.9%-73.3%+106.3%

Beauty Health EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.32 M(-138.5%)
$21.77 M(-166.3%)
Jun 2024
-
$11.22 M(+8.5%)
-$32.82 M(+13.3%)
Mar 2024
-
$10.34 M(+128.2%)
-$28.98 M(-45.9%)
Dec 2023
-$56.00 M(-169.4%)
$4.53 M(-107.7%)
-$53.56 M(+24.8%)
Sep 2023
-
-$58.91 M(-491.2%)
-$42.91 M(-275.7%)
Jun 2023
-
$15.06 M(-205.7%)
$24.42 M(-1.4%)
Mar 2023
-
-$14.25 M(-193.8%)
$24.76 M(-69.7%)
Dec 2022
$80.75 M
$15.19 M(+80.5%)
$81.61 M(+44.7%)
Sep 2022
-
$8.42 M(-45.4%)
$56.41 M(-136.2%)
Jun 2022
-
$15.40 M(-63.9%)
-$155.86 M(-49.2%)
DateAnnualQuarterlyTTM
Mar 2022
-
$42.60 M(-525.8%)
-$306.75 M(-10.7%)
Dec 2021
-$351.08 M(>+9900.0%)
-$10.00 M(-95.1%)
-$343.59 M(+2.6%)
Sep 2021
-
-$203.86 M(+50.5%)
-$334.78 M(+169.1%)
Jun 2021
-
-$135.49 M(-2451.1%)
-$124.39 M(-1846.8%)
Mar 2021
-
$5.76 M(-585.5%)
$7.12 M(-366.3%)
Dec 2020
-$2.81 M(-110.0%)
-$1.19 M(-118.2%)
-$2.67 M(+79.8%)
Sep 2020
-
$6.53 M(-263.9%)
-$1.49 M(-81.4%)
Jun 2020
-
-$3.98 M(-1.3%)
-$8.01 M(+98.7%)
Mar 2020
-
-$4.03 M
-$4.03 M
Dec 2019
$28.04 M(+30.1%)
-
-
Dec 2018
$21.55 M
-
-

FAQ

  • What is Beauty Health annual EBITDA?
  • What is the all time high annual EBITDA for Beauty Health?
  • What is Beauty Health annual EBITDA year-on-year change?
  • What is Beauty Health quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Beauty Health?
  • What is Beauty Health quarterly EBITDA year-on-year change?
  • What is Beauty Health TTM EBITDA?
  • What is the all time high TTM EBITDA for Beauty Health?
  • What is Beauty Health TTM EBITDA year-on-year change?

What is Beauty Health annual EBITDA?

The current annual EBITDA of SKIN is -$56.00 M

What is the all time high annual EBITDA for Beauty Health?

Beauty Health all-time high annual EBITDA is $80.75 M

What is Beauty Health annual EBITDA year-on-year change?

Over the past year, SKIN annual EBITDA has changed by -$136.75 M (-169.35%)

What is Beauty Health quarterly EBITDA?

The current quarterly EBITDA of SKIN is -$4.32 M

What is the all time high quarterly EBITDA for Beauty Health?

Beauty Health all-time high quarterly EBITDA is $42.60 M

What is Beauty Health quarterly EBITDA year-on-year change?

Over the past year, SKIN quarterly EBITDA has changed by +$54.59 M (+92.67%)

What is Beauty Health TTM EBITDA?

The current TTM EBITDA of SKIN is $21.77 M

What is the all time high TTM EBITDA for Beauty Health?

Beauty Health all-time high TTM EBITDA is $81.61 M

What is Beauty Health TTM EBITDA year-on-year change?

Over the past year, SKIN TTM EBITDA has changed by +$64.68 M (+150.74%)